STOCK TITAN

Xencor to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company, announced participation in two upcoming investor conferences focused on oncology and healthcare.

  • Guggenheim Healthcare Talks | 2021 Oncology Days: February 11-12, 2021, with a presentation on February 11 at 1:00 p.m. EST.
  • 10th Annual SVB Leerink Global Healthcare Conference: February 22-26, 2021, with a presentation on February 24 at 3:00 p.m. EST.

Live webcasts will be available on the company's website, with replays for 30 days post-event.

Positive
  • None.
Negative
  • None.

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that company management will participate at two upcoming investor conferences:

  • Guggenheim Healthcare Talks | 2021 Oncology Days
    Conference Dates: February 11-12, 2021
    Presentation Date: Thursday, February 11, 2021
    Presentation Time: 1:00 p.m. EST / 10:00 a.m. PST
  • 10th Annual SVB Leerink Global Healthcare Conference
    Conference Dates: February 22-26, 2021
    Presentation Date: Wednesday, February 24, 2021
    Presentation Time: 3:00 p.m. EST / 12:00 p.m. PST

Live webcasts of the presentations will be available under "Events & Presentations" in the Investors section of the Company's website located at www.xencor.com. Replays will be posted on the Xencor website approximately one hour after the live event and will be available for at least 30 days.

About Xencor, Inc.

Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases. Currently, 20 candidates engineered with Xencor's XmAb® technology are in clinical development internally and with partners. Xencor's XmAb antibody engineering technology enables small changes to the structure of monoclonal antibodies resulting in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.

FAQ

When will Xencor present at the Guggenheim Healthcare Talks?

Xencor will present at the Guggenheim Healthcare Talks on February 11, 2021, at 1:00 p.m. EST.

What are the dates for the 10th Annual SVB Leerink Global Healthcare Conference?

The 10th Annual SVB Leerink Global Healthcare Conference will take place from February 22-26, 2021.

What time is Xencor's presentation at the SVB Leerink Conference?

Xencor's presentation at the SVB Leerink Conference is scheduled for February 24, 2021, at 3:00 p.m. EST.

Where can I watch Xencor's conference presentations?

Xencor's conference presentations can be watched live on their website under the 'Events & Presentations' section.

How long will Xencor's presentation replays be available?

Replays of Xencor's presentations will be available for 30 days after the live events.

Xencor, Inc.

NASDAQ:XNCR

XNCR Rankings

XNCR Latest News

XNCR Stock Data

1.71B
68.81M
0.89%
104.54%
5.86%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
PASADENA